The content in this preview is based on the last saved version of your email - any changes made to your email that have not been saved will not be shown in this preview.

If you have trouble viewing this document, click here to view it as a webpage.

2025 Legislative Update - Week 8


April 25, 2025



Paul D. Seltzer, DO, Legislative Chair

Stephen R. Winn, ED

Michelle W. Larson, Assoc. ED

Jason D. Winn, Esq.

Summary

Week 8 closed with the chambers still $4.4 billion apart on overall spending, a gap primarily driven by the House’s proposed $2.1 billion across-the-board sales-tax cut. During the April 24 floor sessions, Speaker Daniel Perez and President Ben Albritton conceded that the budget would not pass by the scheduled May 2 adjournment, confirming that the budget allocations are not settled and that conference negotiations will not begin this weekend. Absent agreement on allocations, staff cannot draft conforming and implementing bills, effectively pushing any realistic budget vote into an extended or special session.


With the budget process in limbo, the legislature continued hammering out legislation on the floor of both chambers. Nine health care bills have passed both chambers, heading to Governor DeSantis for consideration. Among the bills are HB 0547 Medical Debt, HB 0597 Diabetes Management in Schools, and HB 647, legislation authorizing advanced practice registered nurses providing hospice care to file certificates of death or fetal death and certify the cause of death.

Crongressman Randy Fine & Steve Winn

Representative Michael A. Caruso &

Jason D. Winn, Esq

The stem cell therapy legislation continues moving through the process in both chambers. HB 1617 unanimously cleared its final committee, the Health & Human Services Committee. Senate companion, SB 1768, unanimously passed out of the Senate and is in messages to the House. The legislation authorizes physicians (medical doctors and doctors of osteopathic medicine) to perform stem cell therapies that have not been approved by the U.S. Food and Drug Administration when used for orthopedic conditions, wound care, or pain management. The bill establishes standards for the manufacturing and storing of stem cells. It requires a physician to obtain a signed informed consent form from a patient before administering any such therapy.

pac-donation-logo-web_2_orig image